Chronic Monitoring myBiometry's platform enables remote management of chronic conditions via proprietary sensors, creating sales opportunities with pulmonology clinics, hospital chronic-care programs, and payer-backed remote monitoring initiatives starting with asthma.

Seed Financing A $5M seed round in August 2024 signals investor interest and provides capital for pilots and potential co-development with health systems or pharma partners, accelerating early customer value.

Integration Ready The tech stack shows cloud-based deployment with Azure DNS, Microsoft 365 and analytics plus security tooling (Cloudflare Bot Management, Piwik PRO Core), making it attractive to hospital IT teams seeking compliant, integrable remote-monitoring solutions.

Regional Opportunity Based in Boston with a lean team, there is potential to secure regional pilots with northeastern hospitals and academic centers and then scale to broader markets as the platform expands beyond asthma.

Niche Positioning As a small biomarker-driven remote-monitoring provider, myBiometry can target niche contracts in asthma and other chronic conditions, differentiating from larger incumbents through specialized patient management and data insights.